Increased Incidence of Leucopenia With FDA Approved Valganciclovir Dosing for CMV Prophylaxis in Pediatric Kidney Transplant Recipients.

被引：0
|
作者：
Bhatnagar, S. [1 ]
Palma, K. [1 ]
Palmer, J. [1 ]
Baluarte, J. [1 ]
Amaral, S. [1 ]
机构：
[1] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA
来源：
TRANSPLANTATION | 2014年 / 98卷
关键词：
D O I：
10.1097/00007890-201407151-01671
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
A354
引用
收藏
页码：501 / 501
页数：1
相关论文
共 50 条
  • [1] Increased Incidence of Leucopenia With FDA Approved Valganciclovir Dosing for CMV Prophylaxis in Pediatric Kidney Transplant Recipients
    Bhatnagar, S.
    Palma, K.
    Palmer, J.
    Baluarte, J.
    Amaral, S.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 501 - 501
  • [2] Valganciclovir as CMV prophylaxis in pediatric transplant recipients.
    Bonatti, H
    Wiesmayr, S
    Junngraithmayr, TC
    Margreiter, R
    Zimmerhackl, LB
    [J]. PEDIATRIC TRANSPLANTATION, 2005, 9 : 98 - 98
  • [3] Valganciclovir for CMV prophylaxis in paediatric transplant recipients.
    Wiesmayr, S
    Stelzmueller, I
    Jungraithmayr, T
    Mark, W
    Larcher, C
    Margreiter, R
    Zimmerhackl, L
    Bonatti, H
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 : 355 - 355
  • [4] Extended Valganciclovir Prophylaxis Is Well Tolerated in Pediatric Kidney Transplant Recipients.
    Benchimol, C.
    Tedesco Silva, H., Jr.
    Varela-Fascinetto, G.
    Genevray, M.
    Bradley, D.
    Ives, J.
    [J]. TRANSPLANTATION, 2014, 98 : 497 - 497
  • [5] Valganciclovir is effective prophylaxis for CMV in high risk renal transplant recipients.
    Baillie, GM
    Ashcraft, EE
    Taber, DJ
    Stone, SS
    Emovon, O
    Rogers, J
    Afzal, F
    Lin, A
    Rajagopalan, PR
    Baliga, PK
    Chavin, KD
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 : 377A - 377A
  • [6] A prospective trial of valganciclovir prophylaxis for cytomegalovirus (CMV) prevention in lung transplant recipients.
    Humar, A
    Kumar, D
    Preiksaitis, J
    Fenton, J
    Nia, S
    Jackson, K
    Chernenko, S
    Lien, D
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 : 270 - 270
  • [7] Ganciclovir vs. valganciclovir for CMV prophylaxis in solitary pancreas transplant recipients.
    Rea, DJ
    Kudva, YC
    Larson, TS
    Stegall, MD
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 : 380 - 380
  • [8] Incidence of CMV with dual therapy prophylaxis in renal transplant recipients.
    Baillie, GM
    Ashcraft, EE
    Polito, CC
    Buchanan, EP
    Rodwell, D
    Emovon, O
    Afzal, F
    Rogers, J
    Lin, A
    Brown, E
    Baliga, PK
    Rajagopalan, PR
    Chavin, KD
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 : 780A - 780A
  • [9] A National Survey of Valganciclovir Dosing Strategies in Pediatric Solid Organ Transplant Recipients.
    Shaikh, S.
    Panek, N.
    Park, J.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 889 - 889
  • [10] Ten Years of Low-Dose Valganciclovir; Evaluating the Incidence and Risk Factors of CMV in Kidney Transplant Recipients.
    El Hajj, S.
    Azzi, J.
    Kim, M.
    Gabardi, S.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 948 - 948
12345